Startups
I Peace, Inc.はGMP品質のiPS細胞・培地等の関連製品販売、及びカスタム細胞製造受託サービスをグローバルに展開するCDMOです。PMDA・FDA基準に沿った高品質な細胞製品、および個人向けのiPS細胞バンキングサービスを提供しています。
Mentions in press and media 26
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| May 16, 2026 | Учёные начинают возвращать клетки человека в «молодое» состояние | По словам одного из ведущих учёных, начать можно с восстановления зрения, а затем перейти к внутренним органам. Даже мозг может от этого выиграть. В голливудском блокбастере «Загадочная история Бенджамина Баттона», действие которого происхо... |
| Jul 10, 2025 | Vita Therapeutics and I Peace announced a development program to generate iPS-derived differentiated cells for transplant therapy with an initial focus on FSHD (Facioscapulohumeral Muscular Dystrophy) using universal iPS cells | PALO ALTO, Calif., July 10, 2025 /PRNewswire/ -- Leading GMP cell CDMO I Peace, Inc. (https://ipeace.com/en/), specializing in induced pluripotent stem cells (iPSCs) and iPSC-derived cell therapies, announced that the company has agreed wit... |
| Apr 5, 2025 | I Peace Launches Personalized iPS Cell Services and Longevity Treatment in the U.S. | – Age-Reversed Stem Cell Technology Now Available to the Public – PALO ALTO, Calif., April 5, 2025 /PRNewswire/ -- I Peace, Inc. (https://ipeace.com/en/), a global pioneer in iPSC (induced pluripotent stem cell) technology, proudly announce... |
| Feb 5, 2025 | I Peace establishes and offers low immunoreaction risk GMP iPS Cells | Three lines of GMP iPS Cells derived from type O female blood are now offered as off-the-shelf product PALO ALTO, Calif., Feb. 5, 2025 /PRNewswire/ -- Leading GMP cell CDMO I Peace, Inc. (https://ipeace.com/en/), specializing in induced plu... |
| Dec 31, 2024 | I Peace manufactures 100 lines of GMP iPS Cells cumulatively | Proof of customer recognition of its quality and mass manufacturing capability PALO ALTO, Calif., Dec. 31, 2024 /PRNewswire/ -- Leading GMP cell CDMO I Peace, Inc. (https://ipeace.com/en/), specializing in induced pluripotent stem cells (iP... |
| Oct 30, 2024 | I Peace announces new iPSC lines to reduce immune rejection risk for U.S. population | More than 100 million people in the US have this HLA-A haplotype PALO ALTO, Calif., Oct. 30, 2024 /PRNewswire/ -- Leading GMP cell CDMO I Peace, Inc. (https://www.ipeace.com), specializing in induced pluripotent stem cells (iPSCs) and iPSC-... |
| Aug 22, 2024 | Stem Cell Therapy developers I Peace and iCamuno Biotherapeutics Start Natural Killer Cell Trial for Ovarian Cancer | PALO ALTO, Calif., Aug. 22, 2024 /PRNewswire/ -- I Peace, a pioneering CDMO in induced pluripotent stem (iPS) cells, and iCamuno Biotherapeutics, a biotech company developing iPS cell-based therapies, today announced a significant milestone... |
| Jul 9, 2024 | KOSÉ, I Peace, and Reju Enter Strategic Partnership to Develop Personalized Beauty Products Based on iPS Cells | Demonstration testing of "my own" beauty products PALO ALTO, Calif., July 9, 2024 /PRNewswire/ -- KOSÉ Corporation (Headquarters: Chuo-ku, Tokyo; President: Kazutoshi Kobayashi), I Peace, Inc. (Headquarters: Palo Alto, California,... |
| Jan 31, 2024 | GMP cell CDMO I Peace, Inc. obtains accreditation as ISO 17025: 2017 compliant | Starts undertaking quality evaluation and characterization of iPSCs in accordance with ISO standards PALO ALTO, Calif. , Jan. 30, 2024 /PRNewswire/ -- Leading GMP cell CDMO I Peace, Inc. (https://www.ipeace.com), specializing in induced plu... |
Show more
Reviews 0
FAQ about I Peace, Inc (アイ・ピース株式会社)
What has the press written about I Peace, Inc (アイ・ピース株式会社)?
Parsers VC has collected 26 articles mentioning I Peace, Inc (アイ・ピース株式会社), among them “Учёные начинают возвращать клетки человека в «молодое» состояние” (May 16, 2026) and “Vita Therapeutics and I Peace announced a development program to generate iPS-derived differentiated cells for transplant therapy with an initial focus on FS...” (Jul 10, 2025).
Is I Peace, Inc (アイ・ピース株式会社) still active?
Yes, I Peace, Inc (アイ・ピース株式会社) is active; its latest activity on Parsers VC dates from Oct 2, 2026.